Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases (Q46594525)

23 December 2017

title

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases (English)

1 reference

23 December 2017

0 references

6

1 reference

23 December 2017

author name string

Stephen S Koh

1

1 reference

23 December 2017

Jia-Perng J Wei

2

1 reference

23 December 2017

Xinmin Li

3

1 reference

23 December 2017

Rong R Huang

4

1 reference

23 December 2017

Ngan B Doan

5

1 reference

23 December 2017

Alistair J Cochran

7

1 reference

23 December 2017

Scott W Binder

8

1 reference

23 December 2017

publication date

9 March 2012

1 reference

23 December 2017

published in

Modern Pathology

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

828-837

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.32

exact match

0 references

cites work

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Microarray analysis and tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression profiling of melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Novel genes associated with malignant melanoma but not benign melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

The gene expression signatures of melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

A gene expression signature associated with survival in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

21 January 2018

Maspin: the new frontier

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Biological functions of melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Osteopontin as a molecular prognostic marker for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2012.32

1 reference

23 December 2017

PubMed ID

22411186

1 reference

23 December 2017